Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky

In this episode of the Rapid Response podcast, Alex Oshmyansky, CEO of Cost Plus Drugs, shares his journey in revolutionizing prescription drug pricing. Co-founded with Mark Cuban, the company aims to slash drug costs by revealing their true prices and applying a minimal markup. Oshmyansky faced early challenges in fundraising but secured Cuban's investment through a cold email. He then shifted the company’s focus to drug manufacturing to tackle shortages and further reduce prices. The success of Cost Plus Drugs largely stems from word-of-mouth marketing, which has also shed light on the exploitative practices of Pharmacy Benefit Managers (PBMs), prompting government investigations and potential reforms in the industry. With a background in medicine, Oshmyansky combines patience with strategic boldness, driving the rapid growth and significant influence of Cost Plus Drugs in the pharmaceutical landscape.